Spectrum Pharmaceuticals

A gavel in the foreground with the scale of justice in the background
Biotech

Law firms target Spectrum over lung cancer trial statements

The class actions accuse the biotech of misrepresenting clinical trial data and failing to enroll patients in a confirmatory phase 3 study.
Nick Paul Taylor Jan 24, 2023 8:20am
Parachute

New year, new C-suite execs—Chutes & Ladders

Jan 6, 2023 9:30am
FDA

FDA rejection prompts Spectrum to cut 75% of R&D workforce

Nov 28, 2022 7:50am
Magnifying glass and pills photo

FDA committee vote against Spectrum's Pozenveo

Sep 23, 2022 5:30am
Axe and chopping block

Spectrum trims workforce, R&D to focus on 2 key cancer meds

Jan 5, 2022 10:20am
Parachute

WuXi adds Celgene vet Chang to lead CAR-T—Chutes & Ladders

Jun 5, 2020 9:30am